GI and hepatic company Albireo raises $65M follow-on

On Jan. 25, gastrointestinal and hepatic company Albireo Pharma Inc. (NASDAQ:ALBO) raised $65 million after selling 2 million shares at $33 in a follow-on underwritten by Cowen, William Blair, Needha...